FDA Chief Apologizes for Overstating Plasma Effect on Virus
By MATTHEW PERRONE and DEB RIECHMANN
WASHINGTON (AP) — Food and Drug Administration Commissioner Stephen Hahn is apologizing for overstating the life-saving benefits of using convalescent plasma to treat COVID-19 patients.
Medical experts have been pushing back against the claims since President Donald Trump’s Sunday announcement that the FDA had was issuing emergency authorization for convalescent plasma, which is taken from people who recovered from the disease.
The announcement on the eve of Trump’s Republican National Convention raised suspicions that it was politically motivated to offset critics of the president’s handling of the pandemic.
Hahn had echoed Trump in saying that 35 more people out of 100 would survive the coronavirus if they were treated with convalescent plasma. But that hasn't been established.